Fast Five Quiz: Test Your Knowledge of Metastatic Pancreatic Cancer Pathophysiology, Diagnosis, and Treatment

Michael J. Pishvaian, MD, PhD


September 26, 2018

Pancreatic cancer frequently presents with distant disease, present in approximately 50% of patients upon diagnosis. Pancreatic cancer with distant metastases upon diagnosis has a 5-year survival rate of less than 3%, according to the National Institutes of Health (NIH). Pancreatic cancer is the third most common cause of cancer deaths. Early diagnosis is difficult because of nonspecific and vague symptoms.

The treatment of metastatic disease may incorporate many chemotherapeutic agents. First-line therapy guidelines across various oncology organizations overlap significantly but are not identical. Palliative measures, including pain control and biliary and gastric outlet stenting, should be considered, and other important modalities are additionally recommended.

Test your knowledge of the pathophysiology, diagnosis, and management of metastatic pancreatic cancer with this quiz. Can you recognize and treat metastatic pancreatic cancer?


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.